South Korea
-
Gan & Lee Pharmaceuticals expands Bofanglutide to South Korea with JW Pharmaceutical partnership
The collaboration leverages JW Pharmaceutical’s established research and development capabilities to accelerate the drug’s entry into South Korea’s growing metabolic disease sector.
-
Roche commits USD484M to boost South Korea’s biopharma ecosystem
The company formalized its commitment with South Korea’s Ministry of Health and Welfare to enhance the bio-healthcare industry by supporting international clinical trials and advancing research for innovative medicines.
-
South Korean MedTech firm AdipoLABs opens Asia-Pacific Regional Office in Malaysia to drive healthcare innovation
AdipoLABs operates as a Ministry of Health (MOH)-registered medical device establishment under the Medical Device Authority (MDA), providing regulatory credibility and demonstrating commitment to quality and innovation.
-
SK Biopharmaceuticals expands oncology pipeline with US radiopharmaceutical deal.
WT-7695, a preclinical radiopharmaceutical targeting carbonic anhydrase IX (CA9), was developed in collaboration with the University of Wisconsin-Madison, and SK now holds exclusive worldwide rights to develop, manufacture, and market the drug.